Loading clinical trials...
Loading clinical trials...
The primary purpose of this investigation is to determine the predictive value of task persistence as measured by a mirror tracing task. A secondary purpose is to evaluate differences in task persistence in smokers with or without schizophrenia. It is hypothesized that task persistence in smokers in both diagnostic categories (schizophrenia and no schizophrenia) will predict tobacco dependence treatment outcome at one and six months. It is also hypothesized that smokers with schizophrenia will show lower levels of task persistence after controlling for other motor skills than smokers without schizophrenia.
Please see brief summary above.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
UMDNJ Tobacco Dependence Clinic
New Brunswick, New Jersey, United States
Start Date
February 1, 2005
Primary Completion Date
December 1, 2012
Completion Date
January 1, 2013
Last Updated
July 17, 2017
203
ACTUAL participants
Lead Sponsor
Rutgers, The State University of New Jersey
Collaborators
NCT06543407
NCT06488443
NCT06218056
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions